FDA Inspection 1118873 — Nipro Renal Soultions USA, Corporation
The FDA completed an inspection of Nipro Renal Soultions USA, Corporation on November 12, 2019 in Lewisberry, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 12, 2019
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Lewisberry, PA (United States)